C07D 333/48
By oxygen atoms
Official title: by oxygen atoms
C07D333/48 (By oxygen atoms) appears on 216 US grants and 150 published applications in this corpus.
Search patents in C07D- Granted patents
- 216
- Published applications
- 150
- Assignees
- 143
- Inventors
- 620
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 4 | 0 |
| 1978 | 8 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 7 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 5 | 0 |
| 1985 | 7 | 0 |
| 1986 | 7 | 0 |
| 1987 | 2 | 0 |
| 1988 | 6 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 8 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 0 |
| 2002 | 6 | 8 |
| 2003 | 5 | 11 |
| 2004 | 3 | 7 |
| 2005 | 9 | 10 |
| 2006 | 9 | 3 |
| 2007 | 4 | 6 |
| 2008 | 2 | 2 |
| 2009 | 5 | 6 |
| 2010 | 8 | 10 |
| 2011 | 6 | 2 |
| 2012 | 3 | 2 |
| 2013 | 2 | 3 |
| 2014 | 0 | 3 |
| 2015 | 1 | 6 |
| 2016 | 2 | 10 |
| 2017 | 10 | 3 |
| 2018 | 3 | 13 |
| 2019 | 10 | 4 |
| 2020 | 1 | 3 |
| 2021 | 4 | 7 |
| 2022 | 1 | 4 |
| 2023 | 2 | 6 |
| 2024 | 4 | 5 |
| 2025 | 7 | 12 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Modulators of extracellular signal-regulated kinase7 Apr 2026US 12,595,243 B2Gen1E Lifesciences Inc.
- Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto9 Dec 2025US 12,490,741 B2Corteva Agriscience LLC
- Process for production of new sulfolenic intermediates25 Nov 2025US 12,479,814 B2Dsm IP Assets B.V.
- Process for production of vitamin A9 Sep 2025US 12,410,117 B2Dsm IP Assets B.V.
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Modulators of extracellular signal-regulated kinase9 Jul 2026US 2026/0193225 A1Gen1E Lifesciences Inc.
- Additive for non-aqueous electrolytic solution, non-aqueous electrolytic solution, and power storage device22 Jan 2026US 2026/0024810 A1Sumitomo Seika Chemicals Co., Ltd.
- Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for producing electronic device1 Jan 2026US 2026/0003268 A1FUJIFILM Corporation
- Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto27 Nov 2025US 2025/0359552 A1Corteva Agriscience LLC
Most cited
By later US patents
- Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.71US 7,049,306 B2Elan Pharmaceuticals, Inc. · 2006
- Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses65US 6,673,780 B2Esperion Therapeutics, Inc. · 2004
- Compounds useful as anti-inflammatory agents60US 6,492,393 B1Boehringer Ingelheim Pharmaceuticals, Inc. · 2002
- α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors56US 6,248,775 B1G. D. Searle & Co. · 2001
- Topical application of cis of trans 3,4-thiolanediol to reduce the greasy appearance of hair and skin47US 3,950,532 AL'oreal · 1976